lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
6,507 rows where filing_period = "second_quarter" and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3962914 | ICE MILLER LLP 224bc860-b02a-4dcb-bcba-04969fbf9ece | Q2 | ICE MILLER LLP | 67854 | RESMED CORP. | 2026 | second_quarter | MED | Issues related to ResMed. | HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 0 | 0 | 2026-06-17T08:49:22-04:00 |
| 3963143 | REPUBLIC CONSULTING, LLC 4d1e3e17-a994-4e67-8f5b-4b319cc93dde | Q2 | REPUBLIC CONSULTING, LLC | 401016871 | IQVIA | 2026 | second_quarter | MED | Monitor health data budgets and policy. | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-06-28T12:59:55-04:00 |
| 3963301 | AUBURN HEALTH STRATEGIES, LLC 4d8e883e-058d-48c0-b884-2bd18dd1aee1 | Q2 | AUBURN HEALTH STRATEGIES, LLC | 292697 | AMERICAN PROFICIENCY INSTITUTE | 2026 | second_quarter | MED | proficiency testing for clinical laboratories | 0 | 0 | 2026-06-30T14:59:19-04:00 | |
| 3963588 | RAY C CULVER III f9b2c6a2-3b32-4e69-80c7-2641f147a30b | Q2 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2026 | second_quarter | MED | USDA ARS Human Nutrition Research funding in the FY2026 Agriculture Appropriations (P.L. 119-37) and in the developing FY2027 Agricultural Appropriations bills. USDA ARS Human Nutrition Research funding authority in the reauthorization of the Agriculture Improvement Act of 2018, P.L. 115-334. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-01T18:22:54-04:00 |
| 3963856 | AMERICA'S BLOOD CENTERS e91cce9e-9981-434b-9e8f-c31e2ef1e4c5 | Q2 | AMERICA'S BLOOD CENTERS | 3834 | AMERICA'S BLOOD CENTERS | 2026 | second_quarter | MED | Value of Blood/Reimbursement, laboratory developed tests, infectious disease testing | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-02T17:56:36-04:00 |
| 3964471 | MCDERMOTT+ 85b75f24-7d1d-4cf6-90d6-dfe87bba8e5e | 2T | MCDERMOTT+ LLC | 401103287 | VERILY LIFE SCIENCES LLC | 2026 | second_quarter | MED | Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2026-07-06T14:29:02-04:00 |
| 3964478 | THE UNIVERSITY OF FLORIDA BOARD OF TRUSTEES 9c4e8ef3-9df7-4e68-99af-410a9f7a3d74 | Q2 | THE UNIVERSITY OF FLORIDA BOARD OF TRUSTEES | 401104826 | THE UNIVERSITY OF FLORIDA BOARD OF TRUSTEES | 2026 | second_quarter | MED | FY26 Funding for NIH, University-based research programs Indirect Cost Payments for Research Graduate Student Support Hospital Financing Per Capita Caps (House/Senate) State Directed Payment Program (House/Senate/CMS) Medicaid Provider Tax (House/Senate/CMS) Medicaid Disproportionate Share Hospital (DSH) (House/Senate) One Big Beautiful Bill Act (House/Senate) Accreditation of Medical Schools Mental Health Impact of Cannabis Usage mRNA Vaccine Research and Cancer | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2026-07-06T14:41:38-04:00 |
| 3964588 | BLUEBIRD STRATEGIES a55c3b18-f2e9-4468-8481-56f6c7128242 | Q2 | BLUEBIRD STRATEGIES | 401105447 | MYOTONIC | 2026 | second_quarter | MED | Funding for myotonic dystrophy research as part of the FY27 Congressionally Directed Medical Research Program & Peer Review Medical Research Program. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-06T17:12:03-04:00 |
| 3964597 | BLUEBIRD STRATEGIES 1fcb77dd-3fc4-4d9e-9bdb-86f15e9f43e5 | Q2 | BLUEBIRD STRATEGIES | 401105447 | NCATS ALLIANCE | 2026 | second_quarter | MED | FY27 NIH/NCATS Appropriations Funding | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2026-07-06T17:23:04-04:00 |
| 3964635 | MJL VENTURES, LLC 84f4b40b-baa2-4a05-ae5c-eb183960c2d2 | 2A | MJL VENTURES, LLC | 401110756 | LAW OFFICE OF MICHAEL R. DAVIS, LLC D/B/A/ MRDLAW (OBO DEEP MILE NETWORKS, LLC) | 2026 | second_quarter | MED | Issues related to military healthcare records | Defense, Dept of (DOD) | 0 | 0 | 2026-07-06T20:12:43-04:00 |
| 3964658 | HOLLAND & KNIGHT LLP 081bd8b1-1bdb-495e-9050-07e0b5793146 | Q2 | HOLLAND & KNIGHT LLP | 18466 | RIVERIA INVESTMENT GROUP ON BEHALF OF ON THE RIGHT TRACK | 2026 | second_quarter | MED | FY 2027 Center for Disease Control Appropriations - Request for Centers for Disease Control to update infection control guidelines. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-07T06:42:23-04:00 |
| 3964713 | AMERICAN COLLEGE OF CLINICAL PHARMACY c3f3fd1b-b246-4382-9e81-ec1248d89e9a | Q2 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2026 | second_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-07T10:33:38-04:00 |
| 3964716 | MAGILL ASSOCIATES, LLC 15281d24-137d-4afb-a536-c6d69c9f8667 | Q2 | MAGILL ASSOCIATES, LLC | 401103511 | THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES | 2026 | second_quarter | MED | FY 2027 appropriations for the development of a synthetic vaccine | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-07T10:35:39-04:00 |
| 3964984 | LIFE SCIENCES PENNSYLVANIA 58c29588-60ac-4f2a-a551-01a94d6f3fb4 | Q2 | LIFE SCIENCES PENNSYLVANIA | 401105511 | LIFE SCIENCES PENNSYLVANIA | 2026 | second_quarter | MED | Life Sciences PA supports a robust NIH budget as well as opportunities for Pennsylvania to maintain its leadership role with continued collaborative grant support including the DOD, EDA and NSF. The NIH is the leading investor worldwide in basic scientific research. This funding supports the crucial first step in life sciences investment through discovery and understanding of human biology and physiology. Pennsylvania research institutions and small companies received more than $2 billion in NIH funding in 2023 and, in many cases, hold contractual agreements with the NIH. This research also leads to spin-out companies and technology transfer that perpetuate the cycle of innovation in the Commonwealth. This cut threatens continued research and development in potential treatments and cures for patients. Life Sciences PA joined Pennsylvania patients and researchers at the Rally for Medical Research encouraging Congress to support the highest possible appropriation increase recommended by the medical research community and to complete the FY2026 appropriations process in a timely manner to avoid additional disruptions to the life sciences ecosystem. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-07T15:18:50-04:00 |
| 3965125 | LIVE OAK STRATEGIES 9f01faff-9ccf-4178-b986-8440e1ad7df9 | Q2 | LIVE OAK STRATEGIES | 401105683 | KIMERA LABS | 2026 | second_quarter | MED | Issues related to lab safety. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-07T17:20:00-04:00 |
| 3965611 | DERMATOLOGY ASSOCIATION OF RADIATION THERAPY (DART) 9ee265a6-3cae-4342-85c5-6e0abf80c165 | 2T | DERMATOLOGY ASSOCIATION OF RADIATION THERAPY (DART) | 401109696 | DERMATOLOGY ASSOCIATION OF RADIATION THERAPY (DART) | 2026 | second_quarter | MED | Attention to proposed funding cuts and restrictive coverage policies relating to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule. | 0 | 1 | 2026-07-08T14:07:56-04:00 | |
| 3965620 | PATIENTSACT 2bf7e7d8-c45a-4733-9725-b2bac2cd8d5c | 2T | PATIENTSACT | 401109697 | PATIENTSACT | 2026 | second_quarter | MED | Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule. | 0 | 1 | 2026-07-08T14:13:50-04:00 | |
| 3965671 | CORNERSTONE GOVERNMENT AFFAIRS, INC. f7499bcd-9bd7-45ce-a55d-b184de8db6f7 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | THE UNIVERSITY OF TEXAS SYSTEM | 2026 | second_quarter | MED | Assessing the Systems R&D funding opportunities, designing strategies to pursue funding, and securing funding for research priorities. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-08T15:01:15-04:00 |
| 3966324 | ICE MILLER LLP eff85baf-d760-47ad-841b-8d97b60f5a7b | 2T | ICE MILLER LLP | 67854 | AKRON CHILDREN'S HOSPITAL | 2026 | second_quarter | MED | Issues related to Akron Children's Hospital | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2026-07-09T11:50:37-04:00 |
| 3966360 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 0ab81993-5430-409a-bfc6-77e60c36b113 | Q2 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 312496 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 2026 | second_quarter | MED | vaccines, ACIP, 340B, cdc reform, nih reform, pediatric research, NIH budget, FAIR Act, indirect costs, whole genome sequencing, high cost drugs, CMMI, OMB guidance | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 0 | 0 | 2026-07-09T12:00:31-04:00 |
| 3966571 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 3b635200-9996-4eec-a985-4c8e959ccdf4 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | AMERICAN SOCIETY FOR RADIATION ONCOLOGY | 2026 | second_quarter | MED | Discussions regarding patient access to radiation oncology. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES | 0 | 0 | 2026-07-09T13:28:41-04:00 |
| 3966826 | ICE MILLER LLP 946acd06-b616-4074-9e41-7766ca45ff4f | 2T | ICE MILLER LLP | 67854 | RESMED CORP. | 2026 | second_quarter | MED | Issues related to ResMed. | HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 0 | 1 | 2026-07-09T15:26:22-04:00 |
| 3966922 | WASHINGTON STATE UNIVERSITY 27308a70-48b6-4300-9d61-1085a673cbd0 | Q2 | WASHINGTON STATE UNIVERSITY | 40657 | WASHINGTON STATE UNIVERSITY | 2026 | second_quarter | MED | Substance abuse disorder research | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-09T17:12:35-04:00 |
| 3967085 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 1afe123c-1a82-4d6c-9320-6d3b7fc6126c | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | MMV MEDICINES FOR MALARIA VENTURE | 2026 | second_quarter | MED | The purpose was to increase funding for malaria research in the Department of Defense. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-10T08:39:25-04:00 |
| 3967232 | TERRAPOWER, LLC 4cde5200-dd6c-4487-8401-794b1cb7b3e4 | Q2 | TERRAPOWER, LLC | 401109474 | TERRAPOWER, LLC | 2026 | second_quarter | MED | Implementation of H.R. 3684, Infrastructure Investment and Jobs Act (IIJA); Implementation of H.R 5376 - Inflation Reduction Act of 2022; Implementation of S. 870 - Fire Grants and Safety Act of 2023; Implementation of H.R.1042 - Prohibiting Russian Uranium Imports Act; Implementation of H.R. 1 - One Big Beautiful Act; FY26 Appropriation; Implementation of H.R. 6938 - Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 FY27 Appropriations | Commerce, Dept of (DOC),Defense, Dept of (DOD),Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-10T10:07:35-04:00 |
| 3967277 | CORNERSTONE GOVERNMENT AFFAIRS, INC. e8726553-db4a-4fbb-bc53-05bb8ab1ddba | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | RESPOND-US | 2026 | second_quarter | MED | Educate Congressional teams on military and civilian medical priorities in trauma and combat casualty care across the Defense and civilian healthcare communities. Support FY27 Defense authorization and appropriations for medical readiness and combat casualty care. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-10T10:34:53-04:00 |
| 3967283 | CORNERSTONE GOVERNMENT AFFAIRS, INC. f9dd89d9-4ae3-4f52-8ff2-008080679842 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | GINKGO BIOWORKS, INC. | 2026 | second_quarter | MED | Educated key government stakeholders on Ginkgo Bioworks capabilities in support of wastewater surveillance, and biomanufacturing; support authorization language and appropriations for Defense and Labor, Health, Human Services and Education. | Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-10T10:36:10-04:00 |
| 3967534 | CURE SMA 0b16f63a-cfd7-46ca-914e-ee9212ecf6b8 | Q2 | CURE SMA | 401104586 | CURE SMA | 2026 | second_quarter | MED | medical research in spinal muscular atrophy, development and approval of spinal muscular atrophy treatments, National Institutes of Health funding, U.S. Department of Defense peer reviewed research in spinal muscular atrophy, U.S. Department of Defense Congressionally Directed Medical Research Program funding, Medical Research for Our Troops Act (H.R. 3906) | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2026-07-10T12:10:07-04:00 |
| 3967928 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) d091eb58-828b-4892-9f1d-a17ed86c5418 | Q2 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) | 2970 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) | 2026 | second_quarter | MED | No bill number - Urge NIH to continue funding for therapy research | Natl Institutes of Health (NIH) | 0 | 0 | 2026-07-10T16:25:29-04:00 |
| 3968688 | CORNERSTONE GOVERNMENT AFFAIRS, INC. d202941b-5505-46ce-af8a-7409d1b4b531 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | ADVANCED MATERIALS AND DEVICES, INC. | 2026 | second_quarter | MED | Educated key government stakeholders on AMADs products applicable to the military and supported Defense appropriations requests. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-13T09:11:45-04:00 |
| 3968692 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 68d82723-ab11-4218-934b-30618e6baa4f | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | THE REGENTS OF THE UNIVERSITY OF COLORADO OBO UNIVERSITY OF COLORADO ANSCHUTZ | 2026 | second_quarter | MED | Educated key government stakeholders on the University of Colorados medical capabilities in areas applicable to military health and readiness. Supported Defense authorizations and appropriations. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-13T09:13:45-04:00 |
| 3968695 | CORNERSTONE GOVERNMENT AFFAIRS, INC. fae65adb-13c5-44d7-b413-08c492bf1079 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | NIRSENSE, LLC (FKA BIONICA LABS) | 2026 | second_quarter | MED | Educated key government stakeholders on NIRSenses activities and technologies in support of the Armed Forces and support Defense appropriations requests. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-13T09:15:21-04:00 |
| 3968699 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 6f05c8b0-be5b-41b5-aea9-8e59e1c0bf56 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | THE GENEVA FOUNDATION | 2026 | second_quarter | MED | Educated key government stakeholders on The Geneva Foundations research and development activities in support of US Service members; support Defense appropriations. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-13T09:17:12-04:00 |
| 3968701 | CORNERSTONE GOVERNMENT AFFAIRS, INC. d5d388d9-3ccd-457c-b2d8-29710738046b | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | TELEFLEX INCORPORATED | 2026 | second_quarter | MED | Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members. | Defense, Dept of (DOD) | 0 | 0 | 2026-07-13T09:18:24-04:00 |
| 3968707 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 1e186144-3089-4bc4-a607-0843ddc2f641 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | WASHINGTON STATE UNIVERSITY | 2026 | second_quarter | MED | Educated key government stakeholders on WSUs research and development activities in support of US Service members; support Defense appropriations. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-13T09:21:32-04:00 |
| 3968712 | CORNERSTONE GOVERNMENT AFFAIRS, INC. f9d34b0a-ec26-4f7d-8e3e-052f33e134c8 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | MEDIVIEW XR, INC. | 2026 | second_quarter | MED | Educated government stakeholders on Mediviews technology and capabilities in support of clinical training and graduate medical education; support Defense appropriations. | Defense, Dept of (DOD) | 0 | 0 | 2026-07-13T09:26:07-04:00 |
| 3968744 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 7a7c7095-74aa-47ea-88ce-86dc442bb54d | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | OCTAPHARMA USA, INC. | 2026 | second_quarter | MED | Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security. | Defense, Dept of (DOD),Executive Office of the President (EOP),SENATE | 0 | 0 | 2026-07-13T09:47:47-04:00 |
| 3968780 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 1a7c1c28-4a2b-489f-9cc5-3bf68a9774df | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | CASE WESTERN RESERVE UNIVERSITY | 2026 | second_quarter | MED | Issues related to the FAIR model, federal grants and general higher education issues. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-13T10:10:45-04:00 |
| 3968834 | AMERICAN PHYSICAL THERAPY ASSOCIATION cabe46b7-d527-42ae-9504-b02669325176 | Q2 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 3093 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 2026 | second_quarter | MED | NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding PT role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2026-07-13T10:31:04-04:00 |
| 3968900 | NELSON MULLINS RILEY & SCARBOROUGH e0972807-79c7-4c05-a2cc-a6c1c7e09cb7 | Q2 | NELSON MULLINS RILEY & SCARBOROUGH | 285871 | ANBEX, INC. | 2026 | second_quarter | MED | Stockpile potassium iodide to counteract effects of nuclear radiation. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-13T11:29:53-04:00 |
| 3969011 | FOOD ALLERGY RESEARCH AND EDUCATION (FARE) b5344325-62ae-4303-af50-c160e9c60cf8 | Q2 | FOOD ALLERGY RESEARCH AND EDUCATION (FARE) | 401105387 | FOOD ALLERGY RESEARCH AND EDUCATION (FARE) | 2026 | second_quarter | MED | Advocating for federal funding for food allergy research at the existing 17 clinical sites in the U.S. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-13T12:07:40-04:00 |
| 3969154 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 211ac998-500b-4385-bfc8-d08c89981063 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | THE UNITED STATES PHARMACOPEIAL CONVENTION | 2026 | second_quarter | MED | Issues related to strengthening the resiliency of the U.S. medical supply chain. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-13T13:23:31-04:00 |
| 3969418 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 92832a96-ed3d-4924-93b3-f8b18240a8d7 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | CHILDREN'S NATIONAL MEDICAL CENTER | 2026 | second_quarter | MED | Health-related issues including reimbursement, research, public-health & clinical care. | Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 0 | 0 | 2026-07-13T15:25:09-04:00 |
| 3969437 | CORNERSTONE GOVERNMENT AFFAIRS, INC. d991b14c-eb03-441a-b575-f60d46056501 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | CITY OF HOPE MEDICAL CENTER | 2026 | second_quarter | MED | Issues related to Medicare/Medicaid reimbursement and clinical research. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-13T15:26:36-04:00 |
| 3969713 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 0246c74b-8408-468a-8a1a-243941f9f39a | Q2 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY | 3435 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY | 2026 | second_quarter | MED | Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform; the RESULTS Act | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 0 | 0 | 2026-07-13T18:50:30-04:00 |
| 3970231 | BALLARD PARTNERS 0be624c2-cf09-42a5-ba3d-755deaf973c9 | Q2 | BALLARD PARTNERS | 401104288 | 23ANDME RESEARCH INSTITUTE | 2026 | second_quarter | MED | Government grants, FDA classification, and NIH genomics policy. | Health & Human Services, Dept of (HHS) | 0 | 0 | 2026-07-14T11:19:01-04:00 |
| 3970258 | IMPACT MANAGEMENT GROUP ae7b58b0-790a-4c7d-a584-d78696bdb9b8 | Q2 | IMPACT MANAGEMENT GROUP | 401104137 | CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC. | 2026 | second_quarter | MED | On behalf of Client support continued and future funding for CARTI in Arkansas | HOUSE OF REPRESENTATIVES | 0 | 0 | 2026-07-14T11:28:06-04:00 |
| 3970381 | IMPACT MANAGEMENT GROUP 7c522594-9e5e-4464-ad7e-a216157bd22a | Q2 | IMPACT MANAGEMENT GROUP | 401104137 | ARKANSAS RESEARCH ALLIANCE | 2026 | second_quarter | MED | On behalf of client support continued and future funding for clinical research programs in Arkansas | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-14T11:59:28-04:00 |
| 3970533 | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 3d372a1c-6301-445e-a354-51db7e5ac808 | Q2 | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | 24486 | OSTEAL THERAPEUTICS, INC. | 2026 | second_quarter | MED | General federal government relations | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-14T13:12:14-04:00 |
| 3970685 | ADAMS AND REESE, LLP 60adb6a5-563e-4043-b4d6-9859f4e331f4 | Q2 | ADAMS AND REESE, LLP | 157 | ORCA BIO | 2026 | second_quarter | MED | Assist client with federal legislative governmental relations | Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-14T13:40:05-04:00 |
| 3970725 | SQUIRE PATTON BOGGS 71adccfe-4b19-4a7a-9792-821b78900a16 | Q2 | SQUIRE PATTON BOGGS | 30906 | ALLIANCE FOR BIOSECURITY | 2026 | second_quarter | MED | Preparedness and response as it relates to Biosecurity. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-14T13:53:11-04:00 |
| 3970819 | CALIFORNIA LIFE SCIENCES 4c339e94-0005-4b4e-8e05-94df356f4a96 | Q2 | CALIFORNIA LIFE SCIENCES | 7758 | CALIFORNIA LIFE SCIENCES | 2026 | second_quarter | MED | Support legislation to provide immediate coverage for FDA designated breakthrough medical devices Support robust funding for the NIH in FY2027 appropriations | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-14T14:13:10-04:00 |
| 3970974 | BALLARD PARTNERS 63cf4276-a3f4-4ffe-b933-7c7db22f0fc1 | Q2 | BALLARD PARTNERS | 401104288 | BIOSTAR MEDICAL LLC | 2026 | second_quarter | MED | Promoting the advancement of healthcare technology. | Health & Human Services, Dept of (HHS) | 0 | 0 | 2026-07-14T14:54:22-04:00 |
| 3971371 | BALLARD PARTNERS 5a954165-151d-4409-a1ac-9d3eed49e8cd | Q2 | BALLARD PARTNERS | 401104288 | ERUDIO BIO, INC. | 2026 | second_quarter | MED | Monitoring and interacting with the FDA and other key agencies related to medical devices and AI. Monitoring legislation related to medical devices and AI. | Food & Drug Administration (FDA) | 0 | 0 | 2026-07-14T18:33:48-04:00 |
| 3971638 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 89c0ddbb-cd2c-48ca-aaa4-61c51f99a231 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | THE UNIVERSITY OF TEXAS AT SAN ANTONIO | 2026 | second_quarter | MED | Identify federal funding opportunities and partnerships with federal agencies. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-15T09:32:23-04:00 |
| 3971656 | EFB ADVOCACY, LLC 61eeae9a-dc92-41df-b6eb-d3b85e860e35 | Q2 | EFB ADVOCACY, LLC | 401104430 | ASSOCIATION OF AMERICAN CANCER INSTITUTES | 2026 | second_quarter | MED | Issues related to biomedical research National Institutes of Health appropriations funding | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-15T09:39:28-04:00 |
| 3971690 | EFB ADVOCACY, LLC 2f6d8fc6-5b20-40f2-be52-95edb840d88e | Q2 | EFB ADVOCACY, LLC | 401104430 | UNITED FOR MEDICAL RESEARCH | 2026 | second_quarter | MED | Funding Issues related to the National Institutes of Health | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-15T09:45:24-04:00 |
| 3971795 | SQUIRE PATTON BOGGS 38517640-15d3-4077-86ef-fcbf3ce6d9de | Q2 | SQUIRE PATTON BOGGS | 30906 | LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. | 2026 | second_quarter | MED | Funding support for federally qualified health centers; reauthorization of programs | 0 | 0 | 2026-07-15T10:25:57-04:00 | |
| 3971954 | UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 93f60185-b770-45a4-bc86-74cabeb80648 | Q2 | UNIVERSITY OF MARYLAND, BALTIMORE (UMB) | 401103161 | UNIVERSITY OF MARYLAND, BALTIMORE (UMB) | 2026 | second_quarter | MED | NONE | 0 | 0 | 2026-07-15T11:12:57-04:00 | |
| 3971970 | FEDERAL SOLUTIONS, LLC 3d7c6c8e-6d8f-4da9-a17e-4aa108e31c8e | Q2 | FEDERAL SOLUTIONS, LLC | 311371 | MISSISSIPPI STATE UNIVERSITY | 2026 | second_quarter | MED | Labor/HHS/Education Appropriations: Provisions relating to disease research | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-15T11:14:53-04:00 |
| 3972337 | CORNERSTONE GOVERNMENT AFFAIRS, INC. f370d7f0-5193-43df-b95a-5487f4fb7409 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | LILA SCIENCES, INC. | 2026 | second_quarter | MED | Identifying federal funding and legislative opportunities to support scientific superintelligence coupled with autonomous laboratory environments working in life, chemical, and material sciences. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2026-07-15T12:38:38-04:00 |
| 3972376 | THE CORMAC GROUP, LLC b5d15785-bf19-4c9e-b4ff-c66e6c2d7afc | Q2 | THE CORMAC GROUP, LLC | 66773 | KESSLER FOUNDATION | 2026 | second_quarter | MED | appropriations, DOD, TBI research, veterans issues | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-15T12:44:18-04:00 |
| 3972389 | ZIMMER BIOMET, INC. 902e8d0d-cdfb-4333-9019-c89018d1101c | Q2 | ZIMMER BIOMET, INC. | 292755 | ZIMMER BIOMET, INC. | 2026 | second_quarter | MED | Breakthrough devices; | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-15T12:45:07-04:00 |
| 3972441 | CORNERSTONE GOVERNMENT AFFAIRS, INC. dae295b3-cc38-43c2-9681-494ba4568e10 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM | 2026 | second_quarter | MED | Educated key government stakeholders on the Medical Technology Enterprise Consortiums activities and partnership model in support of Servicemember health and readiness; support Defense appropriations. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-15T12:56:20-04:00 |
| 3972595 | F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES bd0f4f47-89e8-41e3-8649-b1381e4b9d97 | Q2 | F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES | 18411 | F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES | 2026 | second_quarter | MED | (MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Breast and Cervical Cancer, Alzheimer's and Influenza Preparedness Clinical Lab Fee Schedule reform, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act H.R. 5269 / S. 2761 and Medicare coverage of FDA approved breakthrough diagnostics, S.1717 / H.R. 5343 The Ensuring Patient Access to Critical Breakthrough | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-15T13:35:12-04:00 |
| 3972659 | MANATT, PHELPS, AND PHILLIPS 28b81e62-5aaf-481e-9255-db62d15e4c3c | Q2 | MANATT, PHELPS, AND PHILLIPS | 23645 | LOMA LINDA UNIVERSITY MEDICAL CENTER | 2026 | second_quarter | MED | Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-15T13:58:41-04:00 |
| 3972718 | ADAPTIVE GOVERNMENT RELATIONS 80ecb533-b328-45cf-836b-9c85655f537d | Q2 | ADAPTIVE GOVERNMENT RELATIONS | 401110179 | SEATTLE CHILDREN'S | 2026 | second_quarter | MED | NIH and pediatric research | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-15T14:21:10-04:00 |
| 3972844 | CHECKMATE GOVERNMENT RELATIONS 883e9e55-b621-4330-856b-edd7009daed0 | Q2 | CHECKMATE GOVERNMENT RELATIONS | 401109039 | SANOFI US SERVICES INC. | 2026 | second_quarter | MED | There is no current bill filed. Working on Issues related to health care and drug pricing. | Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Health & Human Services, Dept of (HHS),U.S. Trade Representative (USTR),White House Office | 0 | 0 | 2026-07-15T14:57:17-04:00 |
| 3972902 | CORNERSTONE GOVERNMENT AFFAIRS, INC. daee401b-1791-4c73-a475-f62815865d61 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | HAZELDEN BETTY FORD FOUNDATION | 2026 | second_quarter | MED | Educate key government stakeholders on Hazelden Betty Ford Foundation activities in support of substance use and mental health for US Servicemembers and Veterans. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-15T15:15:11-04:00 |
| 3973259 | MISSION ROLL CALL be1cd351-5234-493a-bea6-c649143b77d6 | Q2 | MISSION ROLL CALL | 401110119 | MISSION ROLL CALL | 2026 | second_quarter | MED | HR 740, Veterans' ACCESS Act. Continued direct outreach, policy discussions, and coordination regarding community care access, timely access standards, continuity of care, implementation of community care reforms, and survey-informed legislative analysis supporting congressional engagement. S 800, Precision Brain Health Research Act. Education and advocacy on emerging treatment pathways, innovative brain health initiatives, and prevention-oriented approaches informed by veteran survey research. S 862, HBOT Access Act. Education and advocacy regarding Hyperbaric Oxygen Therapy, pilot programs, evidence development, and innovative treatment options for veterans with TBI and PTSD. HR 72, TBI and PTSD Treatment Act. Education and advocacy on innovative treatment approaches, specialized care, and expanded access to emerging therapies for veterans with traumatic brain injury and PTSD. HR 6993, BEACON Act. Direct engagement and coordination with congressional offices and partner organizations regarding implementation of pilot programs, innovative care models, and traumatic brain injury treatment initiatives. HR 9237 / S 4744, Take Care of America's Veterans Act. Policy analysis, briefing materials, survey-informed legislative evaluation, and engagement regarding proposed reforms to veterans' health care, disability compensation, community care, and Department of Veterans Affairs operations. FY27 National Defense Authorization Act. Review and engagement regarding veterans' health care provisions, innovative treatment initiatives, and amendments affecting veterans' programs. Department of Veterans Affairs workforce reductions and organizational restructuring. Development of survey-informed briefing materials and engagement regarding the potential impacts of workforce reductions on veterans' access to care, VA operations, and service delivery. VA funding and appropriations priorities. No specific legislation. Development of briefing materials, survey-informed insights, and engagement with congressional offices regarding VA… | HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 0 | 0 | 2026-07-15T16:53:35-04:00 |
| 3973302 | BALLARD PARTNERS 8ac34c87-6866-4a5c-952e-e5abe46fa193 | Q2 | BALLARD PARTNERS | 401104288 | INSIGHTEC, INC. | 2026 | second_quarter | MED | Guidance on legislation and regulations regarding medical devices; advocacy regarding the use of medical devices at the VA. | HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 0 | 0 | 2026-07-15T17:06:26-04:00 |
| 3973474 | GOTHAM GOVERNMENT RELATIONS 8e44ccc9-95fb-4fbf-a22f-3810d6fb3b8f | Q2 | GOTHAM GOVERNMENT RELATIONS | 400500471 | OPKO HEALTH, INC. | 2026 | second_quarter | MED | Study/research on Vitamin D deficiency on pregnant women and overweight/obese individuals. | HOUSE OF REPRESENTATIVES | 0 | 0 | 2026-07-15T18:01:56-04:00 |
| 3973503 | BALLARD PARTNERS f620b82a-f473-4a21-93b0-c40404a3645e | Q2 | BALLARD PARTNERS | 401104288 | LIFESCIENCE LOGISTICS | 2026 | second_quarter | MED | Government stockpile storage. | Health & Human Services, Dept of (HHS) | 0 | 0 | 2026-07-15T18:19:18-04:00 |
| 3973548 | HOLLAND & KNIGHT LLP e3ebeda4-b47b-4fe9-98a8-b0d9d8c45b6d | Q2 | HOLLAND & KNIGHT LLP | 18466 | SOUND PHARMACEUTICALS, INC. | 2026 | second_quarter | MED | Issues related to hearing loss and treatment. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-15T18:55:45-04:00 |
| 3973698 | BALLARD PARTNERS 6629a9ad-8a55-4a88-b665-e0d6ebaa3c13 | Q2 | BALLARD PARTNERS | 401104288 | NOVAVAX, INC. | 2026 | second_quarter | MED | Guidance navigating vaccine policy. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-15T23:20:09-04:00 |
| 4024894 | ICE MILLER LLP 224bc860-b02a-4dcb-bcba-04969fbf9ece | Q2 | ICE MILLER LLP | 67854 | RESMED CORP. | 2026 | second_quarter | MED | Issues related to ResMed. | HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 0 | 0 | 2026-06-17T08:49:22-04:00 |
| 4025123 | REPUBLIC CONSULTING, LLC 4d1e3e17-a994-4e67-8f5b-4b319cc93dde | Q2 | REPUBLIC CONSULTING, LLC | 401016871 | IQVIA | 2026 | second_quarter | MED | Monitor health data budgets and policy. | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-06-28T12:59:55-04:00 |
| 4025281 | AUBURN HEALTH STRATEGIES, LLC 4d8e883e-058d-48c0-b884-2bd18dd1aee1 | Q2 | AUBURN HEALTH STRATEGIES, LLC | 292697 | AMERICAN PROFICIENCY INSTITUTE | 2026 | second_quarter | MED | proficiency testing for clinical laboratories | 0 | 0 | 2026-06-30T14:59:19-04:00 | |
| 4025568 | RAY C CULVER III f9b2c6a2-3b32-4e69-80c7-2641f147a30b | Q2 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2026 | second_quarter | MED | USDA ARS Human Nutrition Research funding in the FY2026 Agriculture Appropriations (P.L. 119-37) and in the developing FY2027 Agricultural Appropriations bills. USDA ARS Human Nutrition Research funding authority in the reauthorization of the Agriculture Improvement Act of 2018, P.L. 115-334. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-01T18:22:54-04:00 |
| 4025836 | AMERICA'S BLOOD CENTERS e91cce9e-9981-434b-9e8f-c31e2ef1e4c5 | Q2 | AMERICA'S BLOOD CENTERS | 3834 | AMERICA'S BLOOD CENTERS | 2026 | second_quarter | MED | Value of Blood/Reimbursement, laboratory developed tests, infectious disease testing | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-02T17:56:36-04:00 |
| 4026451 | MCDERMOTT+ 85b75f24-7d1d-4cf6-90d6-dfe87bba8e5e | 2T | MCDERMOTT+ LLC | 401103287 | VERILY LIFE SCIENCES LLC | 2026 | second_quarter | MED | Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2026-07-06T14:29:02-04:00 |
| 4026458 | THE UNIVERSITY OF FLORIDA BOARD OF TRUSTEES 9c4e8ef3-9df7-4e68-99af-410a9f7a3d74 | Q2 | THE UNIVERSITY OF FLORIDA BOARD OF TRUSTEES | 401104826 | THE UNIVERSITY OF FLORIDA BOARD OF TRUSTEES | 2026 | second_quarter | MED | FY26 Funding for NIH, University-based research programs Indirect Cost Payments for Research Graduate Student Support Hospital Financing Per Capita Caps (House/Senate) State Directed Payment Program (House/Senate/CMS) Medicaid Provider Tax (House/Senate/CMS) Medicaid Disproportionate Share Hospital (DSH) (House/Senate) One Big Beautiful Bill Act (House/Senate) Accreditation of Medical Schools Mental Health Impact of Cannabis Usage mRNA Vaccine Research and Cancer | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2026-07-06T14:41:38-04:00 |
| 4026568 | BLUEBIRD STRATEGIES a55c3b18-f2e9-4468-8481-56f6c7128242 | Q2 | BLUEBIRD STRATEGIES | 401105447 | MYOTONIC | 2026 | second_quarter | MED | Funding for myotonic dystrophy research as part of the FY27 Congressionally Directed Medical Research Program & Peer Review Medical Research Program. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-06T17:12:03-04:00 |
| 4026577 | BLUEBIRD STRATEGIES 1fcb77dd-3fc4-4d9e-9bdb-86f15e9f43e5 | Q2 | BLUEBIRD STRATEGIES | 401105447 | NCATS ALLIANCE | 2026 | second_quarter | MED | FY27 NIH/NCATS Appropriations Funding | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2026-07-06T17:23:04-04:00 |
| 4026615 | MJL VENTURES, LLC 84f4b40b-baa2-4a05-ae5c-eb183960c2d2 | 2A | MJL VENTURES, LLC | 401110756 | LAW OFFICE OF MICHAEL R. DAVIS, LLC D/B/A/ MRDLAW (OBO DEEP MILE NETWORKS, LLC) | 2026 | second_quarter | MED | Issues related to military healthcare records | Defense, Dept of (DOD) | 0 | 0 | 2026-07-06T20:12:43-04:00 |
| 4026638 | HOLLAND & KNIGHT LLP 081bd8b1-1bdb-495e-9050-07e0b5793146 | Q2 | HOLLAND & KNIGHT LLP | 18466 | RIVERIA INVESTMENT GROUP ON BEHALF OF ON THE RIGHT TRACK | 2026 | second_quarter | MED | FY 2027 Center for Disease Control Appropriations - Request for Centers for Disease Control to update infection control guidelines. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-07T06:42:23-04:00 |
| 4026693 | AMERICAN COLLEGE OF CLINICAL PHARMACY c3f3fd1b-b246-4382-9e81-ec1248d89e9a | Q2 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2026 | second_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-07T10:33:38-04:00 |
| 4026696 | MAGILL ASSOCIATES, LLC 15281d24-137d-4afb-a536-c6d69c9f8667 | Q2 | MAGILL ASSOCIATES, LLC | 401103511 | THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES | 2026 | second_quarter | MED | FY 2027 appropriations for the development of a synthetic vaccine | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-07T10:35:39-04:00 |
| 4026964 | LIFE SCIENCES PENNSYLVANIA 58c29588-60ac-4f2a-a551-01a94d6f3fb4 | Q2 | LIFE SCIENCES PENNSYLVANIA | 401105511 | LIFE SCIENCES PENNSYLVANIA | 2026 | second_quarter | MED | Life Sciences PA supports a robust NIH budget as well as opportunities for Pennsylvania to maintain its leadership role with continued collaborative grant support including the DOD, EDA and NSF. The NIH is the leading investor worldwide in basic scientific research. This funding supports the crucial first step in life sciences investment through discovery and understanding of human biology and physiology. Pennsylvania research institutions and small companies received more than $2 billion in NIH funding in 2023 and, in many cases, hold contractual agreements with the NIH. This research also leads to spin-out companies and technology transfer that perpetuate the cycle of innovation in the Commonwealth. This cut threatens continued research and development in potential treatments and cures for patients. Life Sciences PA joined Pennsylvania patients and researchers at the Rally for Medical Research encouraging Congress to support the highest possible appropriation increase recommended by the medical research community and to complete the FY2026 appropriations process in a timely manner to avoid additional disruptions to the life sciences ecosystem. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-07T15:18:50-04:00 |
| 4027105 | LIVE OAK STRATEGIES 9f01faff-9ccf-4178-b986-8440e1ad7df9 | Q2 | LIVE OAK STRATEGIES | 401105683 | KIMERA LABS | 2026 | second_quarter | MED | Issues related to lab safety. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-07T17:20:00-04:00 |
| 4027591 | DERMATOLOGY ASSOCIATION OF RADIATION THERAPY (DART) 9ee265a6-3cae-4342-85c5-6e0abf80c165 | 2T | DERMATOLOGY ASSOCIATION OF RADIATION THERAPY (DART) | 401109696 | DERMATOLOGY ASSOCIATION OF RADIATION THERAPY (DART) | 2026 | second_quarter | MED | Attention to proposed funding cuts and restrictive coverage policies relating to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule. | 0 | 1 | 2026-07-08T14:07:56-04:00 | |
| 4027600 | PATIENTSACT 2bf7e7d8-c45a-4733-9725-b2bac2cd8d5c | 2T | PATIENTSACT | 401109697 | PATIENTSACT | 2026 | second_quarter | MED | Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule. | 0 | 1 | 2026-07-08T14:13:50-04:00 | |
| 4027651 | CORNERSTONE GOVERNMENT AFFAIRS, INC. f7499bcd-9bd7-45ce-a55d-b184de8db6f7 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | THE UNIVERSITY OF TEXAS SYSTEM | 2026 | second_quarter | MED | Assessing the Systems R&D funding opportunities, designing strategies to pursue funding, and securing funding for research priorities. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-08T15:01:15-04:00 |
| 4028304 | ICE MILLER LLP eff85baf-d760-47ad-841b-8d97b60f5a7b | 2T | ICE MILLER LLP | 67854 | AKRON CHILDREN'S HOSPITAL | 2026 | second_quarter | MED | Issues related to Akron Children's Hospital | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2026-07-09T11:50:37-04:00 |
| 4028340 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 0ab81993-5430-409a-bfc6-77e60c36b113 | Q2 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 312496 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 2026 | second_quarter | MED | vaccines, ACIP, 340B, cdc reform, nih reform, pediatric research, NIH budget, FAIR Act, indirect costs, whole genome sequencing, high cost drugs, CMMI, OMB guidance | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 0 | 0 | 2026-07-09T12:00:31-04:00 |
| 4028551 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 3b635200-9996-4eec-a985-4c8e959ccdf4 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | AMERICAN SOCIETY FOR RADIATION ONCOLOGY | 2026 | second_quarter | MED | Discussions regarding patient access to radiation oncology. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES | 0 | 0 | 2026-07-09T13:28:41-04:00 |
| 4028806 | ICE MILLER LLP 946acd06-b616-4074-9e41-7766ca45ff4f | 2T | ICE MILLER LLP | 67854 | RESMED CORP. | 2026 | second_quarter | MED | Issues related to ResMed. | HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 0 | 1 | 2026-07-09T15:26:22-04:00 |
| 4028902 | WASHINGTON STATE UNIVERSITY 27308a70-48b6-4300-9d61-1085a673cbd0 | Q2 | WASHINGTON STATE UNIVERSITY | 40657 | WASHINGTON STATE UNIVERSITY | 2026 | second_quarter | MED | Substance abuse disorder research | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-09T17:12:35-04:00 |
| 4029065 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 1afe123c-1a82-4d6c-9320-6d3b7fc6126c | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | MMV MEDICINES FOR MALARIA VENTURE | 2026 | second_quarter | MED | The purpose was to increase funding for malaria research in the Department of Defense. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-10T08:39:25-04:00 |
| 4029212 | TERRAPOWER, LLC 4cde5200-dd6c-4487-8401-794b1cb7b3e4 | Q2 | TERRAPOWER, LLC | 401109474 | TERRAPOWER, LLC | 2026 | second_quarter | MED | Implementation of H.R. 3684, Infrastructure Investment and Jobs Act (IIJA); Implementation of H.R 5376 - Inflation Reduction Act of 2022; Implementation of S. 870 - Fire Grants and Safety Act of 2023; Implementation of H.R.1042 - Prohibiting Russian Uranium Imports Act; Implementation of H.R. 1 - One Big Beautiful Act; FY26 Appropriation; Implementation of H.R. 6938 - Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 FY27 Appropriations | Commerce, Dept of (DOC),Defense, Dept of (DOD),Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2026-07-10T10:07:35-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);